VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers):
breedte van houders +16.7% ·
aandelenstroom +2.2% ·
netto nieuwe posities +14.3%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 10.99M | $194.70M | n/a | −2 |
| Q2 2026 | 148 | -1 | 754.00M | $11.97B | +6 | −8 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | n/a | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | n/a |
| Q2 2024 | 18 | n/a | 121.66M | $1.29B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 48.79M | -14.2% | $566.40M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Geode Capital Management ✦ (passief) | 29.44M | +1.5% | $340.64M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passief) | 11.08M | -12.4% | $128.60M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Glenview Capital ✦ | 7.57M | +16.6% | $87.91M | 1.9% | ▲ Add | 2 | SEC ↗ |
| 5 | Greenlight Capital (DME Capital) ✦ | 7.27M | -1.8% | $84.41M | 3.5% | ▼ Trim | 2 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 6.15M | +719.0% | $71.43M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 4.22M | +2298.4% | $49.03M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | Arrowstreet Capital ✦ | 2.57M | +155.9% | $29.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 2.17M | -29.9% | $25.23M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 10 | Bridgewater Associates ✦ | 1.34M | +253.4% | $15.54M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Gotham Asset Management ✦ | 1.33M | +36.3% | $15.40M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 771.99K | -16.5% | $8.96M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 501.54K | +208.1% | $5.82M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | GAMCO Investors ✦ | 314.12K | -3.7% | $3.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 301.32K | Nieuw | $3.50M | 0.0% | New | 1 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 299.71K | Nieuw | $3.48M | 0.0% | New | 1 | SEC ↗ |
| 17 | Capital World Investors ✦ | 110.68K | 0.0% | $1.28M | 0.0% | Held | 2 | SEC ↗ |
| 18 | Wellington Management ✦ | 61.87K | -20.2% | $718,357 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 19 | Marshall Wace ✦ | 51.62K | -95.3% | $599,273 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 12.59K | -94.2% | $146,170 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Soros Fund Management ✦ | 10.23K | Nieuw | $118,828 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Renaissance Technologies | $3.50M | 0.0% |
| Point72 Asset Management | $3.48M | 0.0% |
| Soros Fund Management | $118,828 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,011 houders, 984.50M aandelen, $12.02B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.